TipRanks
Percheron Therapeutics (PERCF)
OTHER OTC:PERCF
US Market
PERCF
Percheron Therapeutics
RESEARCH TOOLSreports

Percheron Therapeutics (PERCF) Income Statement

13 Followers

Percheron Therapeutics Income Statement

Last quarter (Q4 2026), Percheron Therapeutics's total revenue was AU$0.00, a decrease of ― from the same quarter last year. In Q4, Percheron Therapeutics's net income was AU$-1.69M. See Percheron Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Gross Profit
AU$ -219.56KAU$ -67.98KAU$ -79.42KAU$ -95.20KAU$ -89.22K
Operating Expenses
AU$ 5.40MAU$ 16.64MAU$ 14.80MAU$ 13.25MAU$ 7.52M
Depreciation and Amortization
AU$ 219.56KAU$ 67.98KAU$ 79.42KAU$ 95.20KAU$ 89.22K
EBITDA
AU$ -5.40MAU$ -16.27MAU$ -11.84MAU$ -13.25MAU$ -7.52M
Operating Income
AU$ -5.62MAU$ -16.71MAU$ -14.88MAU$ -13.34MAU$ -7.61M
Other Income/Expenses
AU$ 131.91KAU$ 356.16KAU$ 608.89KAU$ 385.30KAU$ 21.52K
Pretax Income
AU$ -5.49MAU$ -16.35MAU$ -14.27MAU$ -12.96MAU$ -7.59M
Net Income
AU$ -4.79MAU$ -14.92MAU$ -11.92MAU$ -11.38MAU$ -5.81M
Per Share Metrics
Basic EPS
AU$ >-0.01AU$ -0.01AU$ -0.02AU$ -0.02AU$ -0.01
Diluted EPS
AU$ >-0.01AU$ -0.01AU$ -0.02AU$ -0.02AU$ -0.01
Weighted Average Shares Outstanding
 1.17B 1.02B 669.03M 669.03M 634.29M
Weighted Average Shares Outstanding (Diluted)
 1.17B 1.02B 669.03M 669.03M 634.29M
Currency in AUD

Percheron Therapeutics Earnings and Revenue History